Organ Damage, BMI Linked to Fatigue in SLE
Cross-sectional study suggests fatigue is associated with damage accrual and body mass, not disease activity
By
Andrea Surnit
April 20, 2026
Clinical Scorecard: Organ Damage, BMI Linked to Fatigue in SLE
At a Glance
Category Detail
Condition Systemic Lupus Erythematosus (SLE) Key Mechanisms Greater organ damage accrual and higher body mass index associated with fatigue. Target Population Patients with systemic lupus erythematosus, particularly those with clinically significant fatigue. Care Setting Tertiary care center outpatient visits.
Key Highlights
52% of patients exhibited clinically significant fatigue. Higher organ damage scores (mean SLICC/ACR DI: 1.9 vs 1.1) in fatigued patients. Fatigue not correlated with disease activity (mean SELENA-SLEDAI score: 3). Racial differences observed in fatigue reporting, with non-Hispanic Whites more likely to report fatigue. Independent associations found between fatigue and pulmonary fibrosis, neuropathy, and high BMI. Guideline-Based Recommendations
Diagnosis
Assess fatigue using the Fatigue Severity Scale (FSS) with scores of four or higher indicating clinically significant fatigue. Management
Focus on managing organ damage and comorbid conditions, particularly pulmonary fibrosis and neuropathy. Monitoring & Follow-up
Monitor body mass index and organ damage accrual in patients with SLE. Risks
Increased risk of clinically significant fatigue associated with higher BMI and organ damage. Patient & Prescribing Data
183 patients with systemic lupus erythematosus.
No significant association found between fatigue and use of prednisone or hydroxychloroquine.
Clinical Best Practices
Evaluate fatigue in SLE patients regularly using standardized scales. Consider the impact of comorbidities on fatigue levels. Encourage weight management as part of comprehensive care for SLE patients. References
